Active substances
Calcium chloride + Magnesium chloride + Potassium chloride + Sodium chloride
- SFDA 2
- US FDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| HAEMODIALYSIS ACETATE CONC. SOLU.35X F-6 | 210.7,9,5.22,3.56 g/l,g/l,g/l,g/l | Solution · Intravenous use | 1 Bottle | SAR 30.75 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| PLEGISOL SOLN | 6.430 , 3.253 , 1.193 , 0.176 mg/ml | Solution for injection/infusion · Parenteral use | 1 Bag | SAR 65.60 | NCE · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PLEGISOL IN PLASTIC CONTAINER | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | solution · perfusion, cardiac | HOSPIRA | Prescription | 26 Feb 1982 |
| CARDIOPLEGIC IN PLASTIC CONTAINER | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | solution · perfusion, cardiac | BAXTER HLTHCARE | Prescription | 21 Apr 2000 |
| CARDIOPLEGIC IN PLASTIC CONTAINER | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | solution · perfusion, cardiac | FRESENIUS KABI USA | Prescription | 18 Feb 2022 |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.